Drug class in one race
PD-1 + VEGF drugs for Non-Small Cell Lung Cancer
3 tracked PD-1 + VEGF drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PD-1 + VEGF page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
3 Phase 3